YahooAugust 14, 2026 at 11:11 AM NY21 days ago

Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says

Krystal Biotech (KRYS) has further room for gains driven by Vyjuvek, its treatment for the rare blis

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Companies in This Story